MYQORZO
Live / Allowed — Published for opposition (as of 24 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 04 Sept 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99374855
- Mark type
- Stylized text
- Filed
- 04 Sept 2025
- Published for opposition
- 24 Mar 2026
- Attorney of record
- B. Brett Heavner
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for human use, namely, medications to treat cardiovascular conditions; pharmaceutical preparations to treat hypertrophic cardiomyopathies, heart failure, and heart failure with preserved ejection fraction
Owner
- Cytokinetics, Incorporated, South San Francisco, CA, US
- Cytokinetics, Incorporated, South San Francisco, CA, US
Prosecution history
- 24 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Mar 2026 — PUBLISHED FOR OPPOSITION
- 18 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 03 Nov 2025 — NON-FINAL ACTION E-MAILED
- 03 Nov 2025 — NON-FINAL ACTION WRITTEN
- 03 Nov 2025 — ASSIGNED TO EXAMINER
- 04 Sept 2025 — APPLICATION FILING RECEIPT MAILED
- 04 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 Sept 2025 — NEW APPLICATION ENTERED